MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka appeared on the latest episode of the TechMediaWire Podcast to discuss the company's artificial intelligence-driven voice analysis technology. The platform is designed to detect drug and alcohol intoxication through noninvasive speech analysis, offering a scalable alternative to traditional testing methods.
During the interview, Hanka outlined the limitations of current testing approaches, such as breathalyzers and urine tests, which can be invasive, time-consuming, and limited in scope. MindBio's technology leverages over 50 million data points to predict alcohol intoxication with high accuracy using only the human voice. The company is focusing initially on regulated workplace environments, particularly the mining industry, where real-time intoxication screening could enhance safety. Hanka emphasized that the platform is scalable and could be deployed in other sectors such as aviation, construction, and law enforcement.
The podcast episode provides insight into MindBio's commercial strategy and the potential impact of its AI detection platform. The company is developing an enterprise solution that includes Edge-AI kiosks with bespoke hardware and software for detecting drug and alcohol intoxication. This approach aims to expand screening capabilities beyond current methods, offering a noninvasive and continuous monitoring option for high-risk industries.
MindBio's technology represents a significant advancement in workplace safety, as it can detect impairment that might go unnoticed with periodic testing. By enabling real-time detection, the platform could help prevent accidents and improve overall safety standards. The company's focus on the mining industry is strategic, given the sector's stringent safety regulations and high risk of accidents due to impairment.
For more details on the announcement, view the full press release at https://ibn.fm/SU3Ay. Additional information about MindBio and its latest updates can be found in the company's newsroom at https://ibn.fm/MBQIF.